Erasmus MC Cancer Institute
Erasmus MC Cancer Institute
Rotterdam, Netherlands2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Docetaxel or Cabazitaxel With or Without Darolutamide in mCRPC | Metastatic Castration-resistant Prostate Cancer | Recruiting | Phase 2 | 2026-09-10 | NCT05762536 | |
| Impact of CES1 Genotype on Capecitabine Exposure in Cancer Patients | Chemically-Induced Disorders, Digestive System Diseases, Digestive System Neoplasms, Drug Eruptions, Drug-Related Side Effects and Adverse Reactions, Esophageal Neoplasms, Head and Neck Neoplasms, Neoplasms by Site, Skin and Connective Tissue Diseases, colonic disorder, colorectal neoplasm, dermatitis, digestive system disorder, digestive system neoplasm, drug allergy, esophageal cancer, esophageal disorder, hand-foot syndrome, intestinal disorder, neoplasm, rectal disorder, skin disorder | Recruiting | Not stated | 2025-08-11 | NCT07114627 |